337 related articles for article (PubMed ID: 8914270)
21. Solution structure of the human BTK SH3 domain complexed with a proline-rich peptide from p120cbl.
Tzeng SR; Lou YC; Pai MT; Jain ML; Cheng JW
J Biomol NMR; 2000 Apr; 16(4):303-12. PubMed ID: 10826882
[TBL] [Abstract][Full Text] [Related]
22. The human immunodeficiency virus type 1 Nef protein binds the Src-related tyrosine kinase Lck SH2 domain through a novel phosphotyrosine independent mechanism.
Dutartre H; Harris M; Olive D; Collette Y
Virology; 1998 Aug; 247(2):200-11. PubMed ID: 9705913
[TBL] [Abstract][Full Text] [Related]
23. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
[TBL] [Abstract][Full Text] [Related]
24. Solution structure and peptide binding of the SH3 domain from human Fyn.
Morton CJ; Pugh DJ; Brown EL; Kahmann JD; Renzoni DA; Campbell ID
Structure; 1996 Jun; 4(6):705-14. PubMed ID: 8805554
[TBL] [Abstract][Full Text] [Related]
25. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation.
Yamaguchi H; Hendrickson WA
Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479
[TBL] [Abstract][Full Text] [Related]
27. Solution structure and backbone dynamics of the human alpha3-chain type VI collagen C-terminal Kunitz domain,
Sorensen MD; Bjorn S; Norris K; Olsen O; Petersen L; James TL; Led JJ
Biochemistry; 1997 Aug; 36(34):10439-50. PubMed ID: 9265624
[TBL] [Abstract][Full Text] [Related]
28. 1H and 15N NMR assignment and solution structure of the SH3 domain of spectrin: comparison of unrefined and refined structure sets with the crystal structure.
Blanco FJ; Ortiz AR; Serrano L
J Biomol NMR; 1997 Jun; 9(4):347-57. PubMed ID: 9255941
[TBL] [Abstract][Full Text] [Related]
29. Low resolution structure of interleukin-1 beta in solution derived from 1H-15N heteronuclear three-dimensional nuclear magnetic resonance spectroscopy.
Clore GM; Driscoll PC; Wingfield PT; Gronenborn AM
J Mol Biol; 1990 Aug; 214(4):811-7. PubMed ID: 2388269
[TBL] [Abstract][Full Text] [Related]
30. Solution structure of a human cystatin A variant, cystatin A2-98 M65L, by NMR spectroscopy. A possible role of the interactions between the N- and C-termini to maintain the inhibitory active form of cystatin A.
Tate S; Ushioda T; Utsunomiya-Tate N; Shibuya K; Ohyama Y; Nakano Y; Kaji H; Inagaki F; Samejima T; Kainosho M
Biochemistry; 1995 Nov; 34(45):14637-48. PubMed ID: 7578072
[TBL] [Abstract][Full Text] [Related]
31. Solution studies of the SH2 domain from the fyn tyrosine kinase: secondary structure, backbone dynamics and protein association.
Pintar A; Hensmann M; Jumel K; Pitkeathly M; Harding SE; Campbell ID
Eur Biophys J; 1996; 24(6):371-80. PubMed ID: 8765711
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra- and intermolecular interactions.
Erpel T; Superti-Furga G; Courtneidge SA
EMBO J; 1995 Mar; 14(5):963-75. PubMed ID: 7534229
[TBL] [Abstract][Full Text] [Related]
33. Solution structure and dynamics of PEC-60, a protein of the Kazal type inhibitor family, determined by nuclear magnetic resonance spectroscopy.
Liepinsh E; Berndt KD; Sillard R; Mutt V; Otting G
J Mol Biol; 1994 May; 239(1):137-53. PubMed ID: 8196042
[TBL] [Abstract][Full Text] [Related]
34. The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.
Muskett FW; Kelly GP; Whitford D
J Mol Biol; 1996 Apr; 258(1):172-89. PubMed ID: 8613986
[TBL] [Abstract][Full Text] [Related]
35. Nuclear magnetic resonance solution structure of hirudin(1-51) and comparison with corresponding three-dimensional structures determined using the complete 65-residue hirudin polypeptide chain.
Szyperski T; Güntert P; Stone SR; Wüthrich K
J Mol Biol; 1992 Dec; 228(4):1193-205. PubMed ID: 1335515
[TBL] [Abstract][Full Text] [Related]
36. Altered dynamics in Lck SH3 upon binding to the LBD1 domain of Herpesvirus saimiri Tip.
Weis DD; Kjellen P; Sefton BM; Engen JR
Protein Sci; 2006 Oct; 15(10):2402-10. PubMed ID: 17008721
[TBL] [Abstract][Full Text] [Related]
37. Sequence-specific 1H, 13C and 15N resonance assignments of the SH3-SH2 domain pair from the human tyrosine kinase Lck.
Schweimer K; Kiessling A; Bauer F; Hör S; Hoffmann S; Rösch P; Sticht H
J Biomol NMR; 2003 Dec; 27(4):405-6. PubMed ID: 14512743
[No Abstract] [Full Text] [Related]
38. NMR structure of the J-domain and the Gly/Phe-rich region of the Escherichia coli DnaJ chaperone.
Pellecchia M; Szyperski T; Wall D; Georgopoulos C; Wüthrich K
J Mol Biol; 1996 Jul; 260(2):236-50. PubMed ID: 8764403
[TBL] [Abstract][Full Text] [Related]
39. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
Tessari M; Gentile LN; Taylor SJ; Shalloway DI; Nicholson LK; Vuister GW
Biochemistry; 1997 Nov; 36(47):14561-71. PubMed ID: 9398174
[TBL] [Abstract][Full Text] [Related]
40. Distinct binding patterns of HS1 to the Src SH2 and SH3 domains reflect possible mechanisms of recruitment and activation of downstream molecules.
Takemoto Y; Sato M; Furuta M; Hashimoto Y
Int Immunol; 1996 Nov; 8(11):1699-705. PubMed ID: 8943564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
